Symbols / BAX Stock $18.29 -2.64% Baxter International Inc.

Healthcare • Medical Instruments & Supplies • United States • NYQ
BAX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Andrew P. Hider
Exch · Country NYQ · United States
Market Cap 9.44B
Enterprise Value 17.34B
Income -981.00M
Sales 11.32B
FCF (ttm) 900.88M
Book/sh 11.70
Cash/sh 3.90
Employees 37,500
Insider 10d —
IPO Oct 27, 1981
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 3.08%
P/E —
Forward P/E 9.07
PEG 36.68
P/S 0.83
P/B 1.56
P/C —
EV/EBITDA 9.08
EV/Sales 1.53
Quick Ratio 1.02
Current Ratio 1.85
Debt/Eq 161.02
LT Debt/Eq —
EPS (ttm) -1.91
EPS next Y 2.02
EPS Growth —
Revenue Growth 2.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-07-30
Earnings (prior) 2026-04-30
ROA 2.85%
ROE -15.01%
ROIC —
Gross Margin 34.65%
Oper. Margin 6.03%
Profit Margin -9.70%
Shs Outstand 516.47M
Shs Float 513.97M
Insider Own 0.34%
Instit Own 106.62%
Short Float 12.33%
Short Ratio 5.15
Short Interest 40.35M
52W High 32.04
vs 52W High -42.93%
52W Low 15.73
vs 52W Low 16.24%
Beta 0.62
Impl. Vol. 57.32%
Rel Volume 0.51
Avg Volume 8.21M
Volume 4.22M
Target (mean) $21.54
Tgt Median $19.50
Tgt Low $17.00
Tgt High $40.00
# Analysts 12
Recom Hold
Prev Close $18.78
Price $18.29
Change -2.64%
About

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$21.54
Mean price target
2. Current target
$18.29
Latest analyst target
3. DCF / Fair value
$31.40
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$18.29
Low
$17.00
High
$40.00
Mean
$21.54

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-28 down Citigroup Neutral → Sell $17
2026-05-04 main Barclays Overweight → Overweight $27
2026-04-06 main Evercore ISI Group Outperform → Outperform $22
2026-03-11 main Citigroup Neutral → Neutral $19
2026-02-17 main Goldman Sachs Neutral → Neutral $17
2026-02-13 main Barclays Overweight → Overweight $25
2026-01-09 main Barclays Overweight → Overweight $30
2025-12-02 main Morgan Stanley Underweight → Underweight $15
2025-10-31 main Citigroup Neutral → Neutral $21
2025-10-31 main Goldman Sachs Neutral → Neutral $22
2025-10-31 main UBS Neutral → Neutral $21
2025-10-31 down Argus Research Buy → Hold —
2025-10-07 main Evercore ISI Group Outperform → Outperform $31
2025-08-04 main Barclays Overweight → Overweight $36
2025-08-04 down Stifel Buy → Hold $25
2025-08-04 main UBS Neutral → Neutral $24
2025-08-01 main Wells Fargo Equal-Weight → Equal-Weight $24
2025-07-15 main Morgan Stanley Underweight → Underweight $27
2025-07-09 main Citigroup Neutral → Neutral $32
2025-07-08 main Evercore ISI Group Outperform → Outperform $42
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-05 AMPOFO WILLIAM A. II Director — 12,836 $0.00 $0
2026-05-05 WENDELL AMY MCBRIDE Director — 12,836 $0.00 $0
2026-05-05 SHAFER DAVID BRENT Chairman of the Board — 12,836 $0.00 $0
2026-05-05 MCDONNELL MICHAEL R Director — 12,836 $0.00 $0
2026-05-05 WILKES DAVID S. M.D. Director — 12,836 $0.00 $0
2026-05-05 CRAIG JEFFREY A Director — 12,836 $0.00 $0
2026-05-05 SCHLICHTING NANCY M Director — 12,836 $0.00 $0
2026-05-05 MORRISON PATRICIA B Director — 12,836 $0.00 $0
2026-02-27 CARLISLE CYNTHIA Officer — 29,677 $0.00 $0
2026-02-27 SORIANO MARIA CECILIA Officer — 23,742 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
11,244.00
+5.72%
10,636.00
+2.66%
10,360.00
+3.01%
10,057.00
Operating Revenue
11,244.00
+5.72%
10,636.00
+2.66%
10,360.00
+3.01%
10,057.00
Cost Of Revenue
7,865.00
+18.24%
6,652.00
+7.12%
6,210.00
-4.58%
6,508.00
Reconciled Cost Of Revenue
7,865.00
+18.24%
6,652.00
+7.12%
6,210.00
-4.58%
6,508.00
Gross Profit
3,379.00
-15.19%
3,984.00
-4.00%
4,150.00
+16.93%
3,549.00
Operating Expense
3,202.00
-9.68%
3,545.00
+2.96%
3,443.00
-3.88%
3,582.00
Research And Development
518.00
-12.20%
590.00
+13.90%
518.00
+15.11%
450.00
Selling General And Administration
2,890.00
-2.60%
2,967.00
+0.47%
2,953.00
-4.65%
3,097.00
General And Administrative Expense
—
2,967.00
-24.66%
3,938.00
+27.16%
3,097.00
Salaries And Wages
—
—
-42.00
-61.54%
-26.00
Other Gand A
—
2,967.00
-24.66%
3,938.00
+27.16%
3,097.00
Other Operating Expenses
-206.00
-1616.67%
-12.00
+57.14%
-28.00
-180.00%
35.00
Total Expenses
11,067.00
+8.53%
10,197.00
+5.64%
9,653.00
-4.33%
10,090.00
Operating Income
177.00
-59.68%
439.00
-37.91%
707.00
+2242.42%
-33.00
Total Operating Income As Reported
-308.00
-2300.00%
14.00
-98.02%
707.00
+124.85%
-2,845.00
EBITDA
766.00
-31.36%
1,116.00
-35.64%
1,734.00
+198.36%
-1,763.00
Normalized EBITDA
1,261.00
-19.32%
1,563.00
-13.84%
1,814.00
+64.91%
1,100.00
Reconciled Depreciation
981.00
-1.60%
997.00
+1.32%
984.00
-8.21%
1,072.00
EBIT
-215.00
-280.67%
119.00
-84.13%
750.00
+126.46%
-2,835.00
Total Unusual Items
-495.00
-10.74%
-447.00
-458.75%
-80.00
+97.21%
-2,863.00
Total Unusual Items Excluding Goodwill
-495.00
-10.74%
-447.00
-458.75%
-80.00
+97.21%
-2,863.00
Special Income Charges
-478.00
-12.47%
-425.00
-1150.00%
-34.00
+98.82%
-2,877.00
Other Special Charges
-16.00
—
1.00
-98.15%
54.00
Impairment Of Capital Assets
485.00
+14.12%
425.00
0.00
-100.00%
2,812.00
Restructuring And Mergern Acquisition
—
—
-19.00
+51.28%
-39.00
Write Off
9.00
0.00
-100.00%
34.00
0.00
Net Income
-957.00
-47.46%
-649.00
-124.44%
2,656.00
+209.17%
-2,433.00
Pretax Income
-505.00
-74.74%
-289.00
-219.42%
242.00
+107.45%
-3,248.00
Net Non Operating Interest Income Expense
-238.00
+30.21%
-341.00
+22.32%
-439.00
-11.42%
-394.00
Interest Expense Non Operating
290.00
-28.92%
408.00
-19.69%
508.00
+23.00%
413.00
Net Interest Income
-238.00
+30.21%
-341.00
+22.32%
-439.00
-11.42%
-394.00
Interest Expense
290.00
-28.92%
408.00
-19.69%
508.00
+23.00%
413.00
Interest Income Non Operating
52.00
-22.39%
67.00
-2.90%
69.00
+263.16%
19.00
Interest Income
52.00
-22.39%
67.00
-2.90%
69.00
+263.16%
19.00
Other Income Expense
-444.00
-14.73%
-387.00
-1388.46%
-26.00
+99.08%
-2,821.00
Other Non Operating Income Expenses
51.00
-15.00%
60.00
+11.11%
54.00
+28.57%
42.00
Gain On Sale Of Security
-17.00
+22.73%
-22.00
+52.17%
-46.00
-428.57%
14.00
Gain On Sale Of Business
—
0.00
0.00
+100.00%
-65.00
Tax Provision
395.00
+967.57%
37.00
-39.34%
61.00
+145.19%
-135.00
Tax Rate For Calcs
0.00
+0.00%
0.00
-16.67%
0.00
+500.00%
0.00
Tax Effect Of Unusual Items
-103.95
-10.74%
-93.87
-365.63%
-20.16
+83.23%
-120.25
Net Income Including Noncontrolling Interests
-957.00
-50.00%
-638.00
-123.96%
2,663.00
+210.00%
-2,421.00
Net Income From Continuing Operation Net Minority Interest
-900.00
-167.06%
-337.00
-293.68%
174.00
+105.57%
-3,125.00
Net Income From Continuing And Discontinued Operation
-957.00
-47.46%
-649.00
-124.44%
2,656.00
+209.17%
-2,433.00
Net Income Continuous Operations
-900.00
-176.07%
-326.00
-280.11%
181.00
+105.81%
-3,113.00
Net Income Discontinuous Operations
-57.00
+81.73%
-312.00
-112.57%
2,482.00
+258.67%
692.00
Minority Interests
0.00
+100.00%
-11.00
-57.14%
-7.00
+41.67%
-12.00
Normalized Income
-508.95
-3255.30%
16.13
-93.10%
233.84
+161.18%
-382.25
Net Income Common Stockholders
-957.00
-47.46%
-649.00
-124.44%
2,656.00
+209.17%
-2,433.00
Diluted EPS
-1.87
-47.24%
-1.27
-124.19%
5.25
+208.70%
-4.83
Basic EPS
-1.87
-47.24%
-1.27
-124.19%
5.25
+208.70%
-4.83
Basic Average Shares
513.00
+0.59%
510.00
+0.79%
506.00
+0.40%
504.00
Diluted Average Shares
513.00
+0.59%
510.00
+0.79%
506.00
+0.40%
504.00
Diluted NI Availto Com Stockholders
-957.00
-47.46%
-649.00
-124.44%
2,656.00
+209.17%
-2,433.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
20,055.00
-22.21%
25,782.00
-8.82%
28,276.00
-0.04%
28,287.00
Current Assets
6,872.00
-22.38%
8,853.00
-7.78%
9,600.00
+19.84%
8,011.00
Cash Cash Equivalents And Short Term Investments
1,966.00
+11.45%
1,764.00
-42.69%
3,078.00
+79.16%
1,718.00
Cash And Cash Equivalents
1,966.00
+11.45%
1,764.00
-42.69%
3,078.00
+79.16%
1,718.00
Receivables
1,932.00
+11.68%
1,730.00
-2.37%
1,772.00
-32.44%
2,623.00
Accounts Receivable
1,861.00
+10.84%
1,679.00
-2.33%
1,719.00
-33.14%
2,571.00
Gross Accounts Receivable
1,924.00
+9.94%
1,750.00
-1.74%
1,781.00
-33.67%
2,685.00
Allowance For Doubtful Accounts Receivable
-63.00
+11.27%
-71.00
-14.52%
-62.00
+45.61%
-114.00
Other Receivables
71.00
+39.22%
51.00
-3.77%
53.00
+1.92%
52.00
Inventory
2,232.00
+9.09%
2,046.00
+6.67%
1,918.00
-28.41%
2,679.00
Raw Materials
536.00
+5.10%
510.00
-3.77%
530.00
-24.07%
698.00
Work In Process
369.00
+38.72%
266.00
+13.68%
234.00
-20.41%
294.00
Finished Goods
1,327.00
+4.49%
1,270.00
+10.05%
1,154.00
-31.59%
1,687.00
Prepaid Assets
261.00
-28.69%
366.00
+13.66%
322.00
-13.67%
373.00
Current Deferred Assets
—
—
—
—
Assets Held For Sale Current
0.00
-100.00%
2,611.00
+19.83%
2,179.00
+823.31%
236.00
Hedging Assets Current
0.00
-100.00%
8.00
-82.22%
45.00
+221.43%
14.00
Other Current Assets
481.00
+46.65%
328.00
+14.69%
286.00
-22.28%
368.00
Total Non Current Assets
13,183.00
-22.13%
16,929.00
-9.35%
18,676.00
-7.89%
20,276.00
Net PPE
3,186.00
+0.31%
3,176.00
-0.97%
3,207.00
-38.75%
5,236.00
Gross PPE
8,330.00
+4.73%
7,954.00
-0.40%
7,986.00
-29.46%
11,321.00
Accumulated Depreciation
-5,144.00
-7.66%
-4,778.00
+0.02%
-4,779.00
+21.46%
-6,085.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
119.00
+3.48%
115.00
-3.36%
119.00
-13.14%
137.00
Buildings And Improvements
1,402.00
+7.76%
1,301.00
+5.09%
1,238.00
-29.54%
1,757.00
Machinery Furniture Equipment
5,454.00
+8.06%
5,047.00
+2.81%
4,909.00
-22.86%
6,364.00
Construction In Progress
704.00
-1.95%
718.00
+15.06%
624.00
-31.35%
909.00
Other Properties
651.00
-15.78%
773.00
-29.47%
1,096.00
-49.12%
2,154.00
Goodwill And Other Intangible Assets
9,298.00
-11.43%
10,498.00
-10.36%
11,711.00
-11.58%
13,245.00
Goodwill
4,929.00
-6.56%
5,275.00
-8.94%
5,793.00
-10.21%
6,452.00
Other Intangible Assets
4,369.00
-16.35%
5,223.00
-11.74%
5,918.00
-12.88%
6,793.00
Investments And Advances
103.00
-5.50%
109.00
-19.85%
136.00
-44.94%
247.00
Non Current Accounts Receivable
126.00
-4.55%
132.00
-14.29%
154.00
-27.01%
211.00
Non Current Deferred Assets
200.00
-1.96%
204.00
-22.43%
263.00
-6.07%
280.00
Non Current Deferred Taxes Assets
200.00
-1.96%
204.00
-22.43%
263.00
-6.07%
280.00
Other Non Current Assets
204.00
-92.59%
2,754.00
-12.82%
3,159.00
+238.22%
934.00
Total Liabilities Net Minority Interest
13,953.00
-25.62%
18,758.00
-5.30%
19,808.00
-11.54%
22,392.00
Current Liabilities
2,970.00
-54.38%
6,511.00
+0.12%
6,503.00
+37.05%
4,745.00
Payables And Accrued Expenses
2,182.00
+8.02%
2,020.00
+1.97%
1,981.00
-19.11%
2,449.00
Payables
1,183.00
-7.00%
1,272.00
+6.18%
1,198.00
-20.56%
1,508.00
Accounts Payable
999.00
+3.20%
968.00
+9.88%
881.00
-20.63%
1,110.00
Other Payable
—
—
—
—
Dividends Payable
5.00
-94.25%
87.00
-40.82%
147.00
+0.68%
146.00
Current Accrued Expenses
999.00
+33.56%
748.00
-4.47%
783.00
-16.79%
941.00
Employee Benefits
637.00
-6.05%
678.00
-5.04%
714.00
-15.60%
846.00
Pensionand Other Post Retirement Benefit Plans Current
436.00
-10.29%
486.00
-5.45%
514.00
+12.47%
457.00
Total Tax Payable
179.00
-17.51%
217.00
+27.65%
170.00
-32.54%
252.00
Income Tax Payable
83.00
-31.40%
121.00
+55.13%
78.00
-14.29%
91.00
Current Debt And Capital Lease Obligation
84.00
-97.03%
2,832.00
+2.65%
2,759.00
+81.04%
1,524.00
Current Debt
3.00
-99.89%
2,752.00
+3.19%
2,667.00
+89.96%
1,404.00
Other Current Borrowings
3.00
-99.89%
2,752.00
+3.19%
2,667.00
+89.96%
1,404.00
Current Capital Lease Obligation
81.00
+1.25%
80.00
-13.04%
92.00
-23.33%
120.00
Current Deferred Liabilities
141.00
+7.63%
131.00
+2.34%
128.00
-16.88%
154.00
Current Deferred Revenue
141.00
+7.63%
131.00
+2.34%
128.00
-16.88%
154.00
Other Current Liabilities
127.00
-87.81%
1,042.00
-7.05%
1,121.00
+596.27%
161.00
Total Non Current Liabilities Net Minority Interest
10,983.00
-10.32%
12,247.00
-7.95%
13,305.00
-24.60%
17,647.00
Liabilities Heldfor Sale Non Current
0.00
-100.00%
554.00
+0.54%
551.00
+359.17%
120.00
Long Term Debt And Capital Lease Obligation
9,696.00
-8.67%
10,617.00
-6.49%
11,354.00
-27.58%
15,679.00
Long Term Debt
9,473.00
-8.69%
10,374.00
-6.45%
11,089.00
-27.20%
15,232.00
Long Term Capital Lease Obligation
223.00
-8.23%
243.00
-8.30%
265.00
-40.72%
447.00
Long Term Provisions
31.00
+6.90%
29.00
+52.63%
19.00
-5.00%
20.00
Defined Pension Benefit
66.00
+17.86%
56.00
+21.74%
46.00
-62.60%
123.00
Non Current Pension And Other Postretirement Benefit Plans
637.00
-6.05%
678.00
-5.04%
714.00
-15.60%
846.00
Tradeand Other Payables Non Current
146.00
+55.32%
94.00
+30.56%
72.00
+12.50%
64.00
Non Current Deferred Liabilities
281.00
+96.50%
143.00
-67.79%
444.00
-36.66%
701.00
Non Current Deferred Revenue
36.00
-10.00%
40.00
-2.44%
41.00
+2.50%
40.00
Non Current Deferred Taxes Liabilities
245.00
+137.86%
103.00
-74.44%
403.00
-39.03%
661.00
Other Non Current Liabilities
192.00
+45.45%
132.00
-12.58%
151.00
-30.41%
217.00
Stockholders Equity
6,129.00
-11.99%
6,964.00
-17.11%
8,402.00
+44.04%
5,833.00
Common Stock Equity
6,129.00
-11.99%
6,964.00
-17.11%
8,402.00
+44.04%
5,833.00
Capital Stock
683.00
+0.00%
683.00
+0.00%
683.00
+0.00%
683.00
Common Stock
683.00
+0.00%
683.00
+0.00%
683.00
+0.00%
683.00
Share Issued
683.49
+0.00%
683.49
+0.00%
683.49
+0.00%
683.49
Ordinary Shares Number
514.28
+0.66%
510.93
+0.65%
507.63
+0.63%
504.43
Treasury Shares Number
169.21
-1.94%
172.57
-1.87%
175.86
-1.79%
179.06
Additional Paid In Capital
6,368.00
-0.83%
6,421.00
+0.50%
6,389.00
+1.06%
6,322.00
Retained Earnings
13,705.00
-8.20%
14,929.00
-7.35%
16,114.00
+14.69%
14,050.00
Gains Losses Not Affecting Retained Earnings
-3,754.00
+6.38%
-4,010.00
-12.83%
-3,554.00
+7.28%
-3,833.00
Treasury Stock
10,873.00
-1.68%
11,059.00
-1.52%
11,230.00
-1.40%
11,389.00
Minority Interest
-27.00
-145.00%
60.00
-9.09%
66.00
+6.45%
62.00
Other Equity Adjustments
-3,754.00
+6.38%
-4,010.00
-12.83%
-3,554.00
+7.28%
-3,833.00
Total Equity Gross Minority Interest
6,102.00
-13.13%
7,024.00
-17.05%
8,468.00
+43.65%
5,895.00
Total Capitalization
15,602.00
-10.01%
17,338.00
-11.05%
19,491.00
-7.47%
21,065.00
Working Capital
3,902.00
+66.61%
2,342.00
-24.38%
3,097.00
-5.17%
3,266.00
Invested Capital
15,605.00
-22.32%
20,090.00
-9.33%
22,158.00
-1.38%
22,469.00
Total Debt
9,780.00
-27.28%
13,449.00
-4.70%
14,113.00
-17.96%
17,203.00
Net Debt
7,510.00
-33.90%
11,362.00
+6.41%
10,678.00
-28.42%
14,918.00
Capital Lease Obligations
304.00
-5.88%
323.00
-9.52%
357.00
-37.04%
567.00
Net Tangible Assets
-3,169.00
+10.33%
-3,534.00
-6.80%
-3,309.00
+55.36%
-7,412.00
Tangible Book Value
-3,169.00
+10.33%
-3,534.00
-6.80%
-3,309.00
+55.36%
-7,412.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
845.00
-17.08%
1,019.00
-40.96%
1,726.00
+42.53%
1,211.00
Cash Flow From Continuing Operating Activities
951.00
+16.12%
819.00
-32.15%
1,207.00
+128.60%
528.00
Cash From Discontinued Operating Activities
-106.00
-153.00%
200.00
-61.46%
519.00
-24.01%
683.00
Net Income From Continuing Operations
-900.00
-176.07%
-326.00
-280.11%
181.00
+105.81%
-3,113.00
Depreciation Amortization Depletion
981.00
-1.60%
997.00
+1.32%
984.00
-8.21%
1,072.00
Depreciation
383.00
+2.96%
372.00
-5.58%
394.00
+0.25%
393.00
Amortization Cash Flow
598.00
-4.32%
625.00
+5.93%
590.00
-13.11%
679.00
Depreciation And Amortization
981.00
-1.60%
997.00
+1.32%
984.00
-8.21%
1,072.00
Amortization Of Intangibles
598.00
-4.32%
625.00
+5.93%
590.00
-13.11%
679.00
Other Non Cash Items
30.00
-26.83%
41.00
-33.87%
62.00
+255.00%
-40.00
Pension And Employee Benefit Expense
-32.00
-14.29%
-28.00
+3.45%
-29.00
-196.67%
30.00
Stock Based Compensation
117.00
+2.63%
114.00
-0.87%
115.00
-17.86%
140.00
Asset Impairment Charge
802.00
+54.53%
519.00
+4818.18%
-11.00
-100.35%
3,165.00
Deferred Tax
77.00
+129.39%
-262.00
-2.34%
-256.00
+1.54%
-260.00
Deferred Income Tax
77.00
+129.39%
-262.00
-2.34%
-256.00
+1.54%
-260.00
Operating Gains Losses
-48.00
-71.43%
-28.00
+3.45%
-29.00
-117.06%
170.00
Net Foreign Currency Exchange Gain Loss
—
0.00
0.00
-100.00%
65.00
Change In Working Capital
-108.00
+54.24%
-236.00
-246.58%
161.00
+126.57%
-606.00
Change In Receivables
-132.00
-277.14%
-35.00
+7.89%
-38.00
+20.83%
-48.00
Changes In Account Receivables
-132.00
-277.14%
-35.00
+7.89%
-38.00
+20.83%
-48.00
Change In Inventory
-119.00
+40.80%
-201.00
-57.03%
-128.00
+35.35%
-198.00
Change In Prepaid Assets
72.00
+157.60%
-125.00
-177.78%
-45.00
-2.27%
-44.00
Change In Payables And Accrued Expense
152.00
-2.56%
156.00
-59.48%
385.00
+271.11%
-225.00
Change In Accrued Expense
149.00
+238.64%
44.00
-84.98%
293.00
+285.44%
-158.00
Change In Payable
3.00
-97.32%
112.00
+21.74%
92.00
+237.31%
-67.00
Change In Account Payable
3.00
-97.32%
112.00
+21.74%
92.00
+237.31%
-67.00
Change In Other Working Capital
-81.00
-161.29%
-31.00
-138.46%
-13.00
+85.71%
-91.00
Investing Cash Flow
2,841.00
+553.83%
-626.00
-119.48%
3,213.00
+445.11%
-931.00
Cash Flow From Continuing Investing Activities
-464.00
-13.17%
-410.00
+0.00%
-410.00
+34.29%
-624.00
Cash From Discontinued Investing Activities
3,305.00
+1630.09%
-216.00
-105.96%
3,623.00
+1280.13%
-307.00
Capital Expenditure
-522.00
-13.48%
-460.00
-5.50%
-436.00
+31.34%
-635.00
Capital Expenditure Reported
-513.00
-15.02%
-446.00
-3.24%
-432.00
-14.59%
-377.00
Net Investment Purchase And Sale
0.00
-100.00%
34.00
0.00
0.00
Sale Of Investment
0.00
-100.00%
34.00
0.00
0.00
Net Business Purchase And Sale
—
—
-6.00
+97.72%
-263.00
Purchase Of Business
—
—
-6.00
+97.72%
-263.00
Gain Loss On Sale Of Business
—
0.00
0.00
-100.00%
75.00
Net Intangibles Purchase And Sale
-9.00
+35.71%
-14.00
-250.00%
-4.00
+98.45%
-258.00
Purchase Of Intangibles
-9.00
+35.71%
-14.00
-250.00%
-4.00
+98.45%
-258.00
Net Other Investing Changes
58.00
+262.50%
16.00
-38.46%
26.00
+136.36%
11.00
Financing Cash Flow
-4,216.00
-290.01%
-1,081.00
+69.02%
-3,489.00
-142.63%
-1,438.00
Cash Flow From Continuing Financing Activities
-4,216.00
-290.01%
-1,081.00
+69.02%
-3,489.00
-142.63%
-1,438.00
Net Issuance Payments Of Debt
-3,791.00
-613.94%
-531.00
+81.91%
-2,935.00
-226.47%
-899.00
Issuance Of Debt
1,998.00
-6.02%
2,126.00
0.00
-100.00%
55.00
Repayment Of Debt
-5,789.00
-117.88%
-2,657.00
+9.47%
-2,935.00
-207.65%
-954.00
Long Term Debt Issuance
1,998.00
0.00
0.00
0.00
Long Term Debt Payments
-5,489.00
-106.59%
-2,657.00
-0.87%
-2,634.00
-176.10%
-954.00
Net Long Term Debt Issuance
-3,491.00
-31.39%
-2,657.00
-0.87%
-2,634.00
-176.10%
-954.00
Short Term Debt Issuance
0.00
-100.00%
2,126.00
0.00
-100.00%
55.00
Short Term Debt Payments
-300.00
—
-301.00
—
Net Short Term Debt Issuance
-300.00
-114.11%
2,126.00
+806.31%
-301.00
-647.27%
55.00
Net Common Stock Issuance
—
0.00
0.00
+100.00%
-32.00
Common Stock Payments
—
0.00
0.00
+100.00%
-32.00
Common Stock Dividend Paid
-348.00
+41.02%
-590.00
-0.68%
-586.00
-2.27%
-573.00
Cash Dividends Paid
-348.00
+41.02%
-590.00
-0.68%
-586.00
-2.27%
-573.00
Repurchase Of Capital Stock
—
0.00
0.00
+100.00%
-32.00
Proceeds From Stock Option Exercised
30.00
-57.75%
71.00
-25.26%
95.00
-25.20%
127.00
Net Other Financing Charges
-107.00
-245.16%
-31.00
+50.79%
-63.00
-3.28%
-61.00
Changes In Cash
-530.00
+22.97%
-688.00
-147.45%
1,450.00
+225.22%
-1,158.00
Effect Of Exchange Rate Changes
84.00
+187.50%
-96.00
-469.23%
26.00
+134.21%
-76.00
Beginning Cash Position
2,414.00
-24.52%
3,198.00
+85.71%
1,722.00
-41.75%
2,956.00
End Cash Position
1,968.00
-18.48%
2,414.00
-24.52%
3,198.00
+85.71%
1,722.00
Free Cash Flow
323.00
-42.22%
559.00
-56.67%
1,290.00
+123.96%
576.00
Interest Paid Supplemental Data
303.00
-24.44%
401.00
-17.15%
484.00
+36.34%
355.00
Income Tax Paid Supplemental Data
—
223.00
+28.16%
174.00
+3.57%
168.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category